- Home
- IMXI vs PROK Comparison
IMXI vs PROK Comparison
Compare IMXI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMXI
- PROK
- Stock Information
- Founded
- IMXI 1994
- PROK 2015
- Country
- IMXI United States
- PROK United States
- Employees
- IMXI N/A
- PROK N/A
- Industry
- IMXI Retail: Computer Software & Peripheral Equipment
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMXI Technology
- PROK Health Care
- Exchange
- IMXI Nasdaq
- PROK Nasdaq
- Market Cap
- IMXI 438.1M
- PROK 417.1M
- IPO Year
- IMXI N/A
- PROK N/A
- Fundamental
- Price
- IMXI $15.16
- PROK $2.11
- Analyst Decision
- IMXI Buy
- PROK Strong Buy
- Analyst Count
- IMXI 3
- PROK 4
- Target Price
- IMXI $16.67
- PROK $6.25
- AVG Volume (30 Days)
- IMXI 242.8K
- PROK 1.5M
- Earning Date
- IMXI 11-10-2025
- PROK 11-10-2025
- Dividend Yield
- IMXI N/A
- PROK N/A
- EPS Growth
- IMXI N/A
- PROK N/A
- EPS
- IMXI 1.29
- PROK N/A
- Revenue
- IMXI $625,123,000.00
- PROK $744,000.00
- Revenue This Year
- IMXI N/A
- PROK $471.74
- Revenue Next Year
- IMXI $1.87
- PROK N/A
- P/E Ratio
- IMXI $11.73
- PROK N/A
- Revenue Growth
- IMXI N/A
- PROK N/A
- 52 Week Low
- IMXI $8.58
- PROK $0.46
- 52 Week High
- IMXI $22.30
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- IMXI 66.73
- PROK 34.46
- Support Level
- IMXI $15.06
- PROK $2.08
- Resistance Level
- IMXI $15.12
- PROK $2.25
- Average True Range (ATR)
- IMXI 0.07
- PROK 0.23
- MACD
- IMXI -0.02
- PROK -0.05
- Stochastic Oscillator
- IMXI 77.50
- PROK 7.14
About IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.